1. Home
  2. IMAB vs ORMP Comparison

IMAB vs ORMP Comparison

Compare IMAB & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • ORMP
  • Stock Information
  • Founded
  • IMAB 2014
  • ORMP 2002
  • Country
  • IMAB United States
  • ORMP United States
  • Employees
  • IMAB 220
  • ORMP N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • ORMP Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMAB Health Care
  • ORMP Health Care
  • Exchange
  • IMAB Nasdaq
  • ORMP Nasdaq
  • Market Cap
  • IMAB 79.9M
  • ORMP 90.7M
  • IPO Year
  • IMAB 2020
  • ORMP N/A
  • Fundamental
  • Price
  • IMAB $0.99
  • ORMP $2.17
  • Analyst Decision
  • IMAB Strong Buy
  • ORMP Hold
  • Analyst Count
  • IMAB 3
  • ORMP 1
  • Target Price
  • IMAB $8.00
  • ORMP N/A
  • AVG Volume (30 Days)
  • IMAB 274.1K
  • ORMP 113.9K
  • Earning Date
  • IMAB 03-13-2025
  • ORMP 03-05-2025
  • Dividend Yield
  • IMAB N/A
  • ORMP N/A
  • EPS Growth
  • IMAB N/A
  • ORMP N/A
  • EPS
  • IMAB N/A
  • ORMP 0.11
  • Revenue
  • IMAB $3,313,984.00
  • ORMP N/A
  • Revenue This Year
  • IMAB N/A
  • ORMP N/A
  • Revenue Next Year
  • IMAB N/A
  • ORMP N/A
  • P/E Ratio
  • IMAB N/A
  • ORMP $19.82
  • Revenue Growth
  • IMAB N/A
  • ORMP N/A
  • 52 Week Low
  • IMAB $0.84
  • ORMP $2.00
  • 52 Week High
  • IMAB $2.08
  • ORMP $3.67
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 43.19
  • ORMP 36.05
  • Support Level
  • IMAB $1.03
  • ORMP $2.12
  • Resistance Level
  • IMAB $1.10
  • ORMP $2.27
  • Average True Range (ATR)
  • IMAB 0.06
  • ORMP 0.07
  • MACD
  • IMAB -0.01
  • ORMP -0.01
  • Stochastic Oscillator
  • IMAB 7.58
  • ORMP 22.73

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Share on Social Networks: